Vermont committee to begin studying medical marijuana program for improvements
The Vermont Cannabis Control Board (CCB) is inviting stakeholders to have their voices heard regarding the state’s medical cannabis program. In compliance with Act 65, the CCB has announced a series of four remote meetings over the summer and fall, aimed at gathering public insights and recommendations on a range of key areas. The law requires the CCB to collaborate with the Vermont Academic Detailing Program, patients and caregivers, licensed medical cannabis dispensaries, and healthcare professionals. Together, they are tasked with evaluating and making recommendations for Vermont’s medical cannabis program. Topics for discussion include determining the conditions that qualify for medical cannabis, identifying appropriate strains for specific conditions, setting dosing and treatment standards, and exploring any other avenues that might enhance the program.
On Starting Tuesday, August 8th, from 10:00am – 12:00pm, members of the public can join the first meeting via Microsoft Teams, with the link available on the CCB’s website. If unable to attend, stakeholders are encouraged to submit their recommendations by emailing CCB.Med@vermont.gov, including the subject line “STAKEHOLDER RECOMMENDATIONS.” The CCB is also open to receiving nominations for individuals that would actively participate in the study committee. This collaborative effort signals a promising step towards fine-tuning Vermont’s medical cannabis program, with the shared insights and feedback of stakeholders.